title: [Spaniomenorrhea and hypermenorrhea in the female adolescent. Aspects and management].
abstract: Ninety percent of cases of metrorrhagia during puberty are of functional origin and related to short, monophasic cycles. Emergency care may sometimes necessitate rapid administration of estrogens. Treatment of the underlying condition involves the administration of progestogens 10 days per cycle or, less frequently, artificial cycles. Spaniomenorrhea during puberty may, less commonly, be due to ovarian dystrophy. Functional forms should be treated only if they are accompanied by mastopathy.
mesh_terms: D000293:Adolescent; D000726:Androgen Antagonists / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D005260:Female; D005833:Genital Neoplasms, Female / Q000150:complications; D006402:Hematologic Diseases / Q000150:complications; D006801:Humans; D008595:Menorrhagia / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D008599:Menstruation Disturbances / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D008796:Metrorrhagia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D010911:Pituitary Neoplasms / Q000150:complications; D011085:Polycystic Ovary Syndrome / Q000150:complications; D045167:Progesterone Congeners / Q000627:therapeutic use
chemical_list: D000726:Androgen Antagonists; D000933:Antifibrinolytic Agents; D045167:Progesterone Congeners
vernacular_title: Spanioménorrhée et hyperménorrhée de l'adolescente. Aspect et conduite à tenir.